Table 3.
Type of Treatment | All | Low RS | Intermediate RS | High RS | P Value |
---|---|---|---|---|---|
All T categories | |||||
| |||||
HT alone | 722 (71.7) | 513 (91.4) | 201 (56.2) | 8 (9.1) | <.0001 |
CT alone | 2 (0.2) | 0 | 0 | 2 (2.3) | |
CT-HT | 266 (26.4) | 36 (6.4) | 153 (42.7) | 77 (87.5) | |
No treatment | 17 (1.7) | 12 (2.2) | 4 (1.1) | 1 (1.1) | |
Missing treatment data | 23 | 10 | 12 | 1 | |
Total | 1030 | 571 | 370 | 89 | |
| |||||
T1a | |||||
| |||||
HT alone | 33 (94) | 21 (100) | 12 (92) | 0 | .0219 |
CT-HT | 2 (6) | 0 | 1 (8) | 1 (100) | |
Total | 35 | 21 | 13 | 1 | |
| |||||
T1b | |||||
| |||||
HT alone | 204 (75.3) | 147 (96.1) | 56 (58.9) | 1 (4.3) | <.0001 |
CT-HT | 67 (24.7) | 6 (3.9) | 39 (41.1) | 22 (95.7) | |
Total | 271 | 153 | 95 | 23 | |
| |||||
T1c | |||||
| |||||
HT alone | 485 (71.1) | 345 (92.0) | 133 (54.1) | 7 (11.5) | <.0001 |
CT-HT | 197 (28.9) | 30 (8.0) | 113 (45.9) | 54 (88.5) | |
Total | 682 | 375 | 246 | 61 |
Abbreviations: CT, chemotherapy; HT, hormonal therapy; CT-HT, CT followed by HT.
Values in table are number of patients (%) unless otherwise specified. Percentages of patients who received HT alone and CT-HT were calculated after exclusion of patients who received non-guideline-recommended treatments (CT alone, therapeutic abstention) or had missing data.